Evidence map›Paper›PMID 40406768›Full record

ArticleCureus2025

Gastric Metastasis From Clear Cell Renal Cell Carcinoma: A Case Report.

Nuno Gonçalves, Cristina Monteiro, Luísa Calais Pereira, João Pedro Mendes, José Paulo Couto

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nuno GonçalvesGeneral Surgery, Unidade Local de Saúde do Alto Minho, Viana do Castelo, PRT.
Cristina MonteiroGeneral Surgery, Unidade Local de Saúde do Alto Minho, Viana do Castelo, PRT.
Luísa Calais PereiraGeneral Surgery, Unidade Local de Saúde do Alto Minho, Viana do Castelo, PRT.
João Pedro MendesGeneral Surgery, Unidade Local de Saúde do Alto Minho, Viana do Castelo, PRT.
José Paulo CoutoGeneral Surgery, Unidade Local de Saúde do Alto Minho, Viana do Castelo, PRT.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gastric metastases from solid tumors are rare and often clinically silent. When present, they typically originate from primaries such as the lung, breast, or skin. Renal cell carcinoma (RCC), particularly the clear cell subtype, has a known metastatic potential, most commonly to the lungs, bones, and liver. Gastric involvement is extremely uncommon. We report a case of an 83-year-old man with a remote history of clear cell RCC treated with nephrectomy three decades earlier, who presented with melena, epigastric discomfort, and vomiting. Endoscopic evaluation revealed a conglomerate of friable, vegetative lesions in the stomach with signs of recent bleeding. Biopsies confirmed metastasis of clear cell RCC. Computed tomography (CT) imaging demonstrated multiple nodular intraluminal gastric lesions. Given the patient's advanced age, comorbidities, and known distant metastases, surgical treatment was deemed inappropriate. Palliative hemostatic radiotherapy was initiated for symptom control. This case highlights the potential for late gastric metastasis from clear cell RCC and emphasizes the importance of considering metastatic disease in the differential diagnosis of gastrointestinal bleeding, even decades after the initial oncologic treatment. Prompt endoscopic evaluation and histological confirmation are essential for diagnosis, while treatment decisions must be individualized based on disease burden and patient condition.

Indexed as

case reportgastric metastasisgastrointestinal bleedingpalliative careradiotherapyrenal cell carcinoma

Identifiers

PMID40406768
PMCPMC12097801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.